Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-23-012135
Filing Date
2023-04-13
Accepted
2023-04-13 16:15:16
Documents
3
Period of Report
2023-04-13

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 757157
2 proxy_001.jpg GRAPHIC 210611
3 proxy_002.jpg GRAPHIC 310657
  Complete submission text file 0001493152-23-012135.txt   1476615
Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-15771 | Film No.: 23818517
SIC: 2834 Pharmaceutical Preparations